Back to Search Start Over

Disruption of TIGAR-TAK1 alleviates immunopathology in a murine model of sepsis.

Authors :
Wang D
Li Y
Yang H
Shen X
Shi X
Li C
Zhang Y
Liu X
Jiang B
Zhu X
Zhang H
Li X
Bai H
Yang Q
Gao W
Bai F
Ji Y
Chen Q
Ben J
Source :
Nature communications [Nat Commun] 2024 May 21; Vol. 15 (1), pp. 4340. Date of Electronic Publication: 2024 May 21.
Publication Year :
2024

Abstract

Macrophage-orchestrated inflammation contributes to multiple diseases including sepsis. However, the underlying mechanisms remain to be defined clearly. Here, we show that macrophage TP53-induced glycolysis and apoptosis regulator (TIGAR) is up-regulated in murine sepsis models. When myeloid Tigar is ablated, sepsis induced by either lipopolysaccharide treatment or cecal ligation puncture in male mice is attenuated via inflammation inhibition. Mechanistic characterizations indicate that TIGAR directly binds to transforming growth factor β-activated kinase (TAK1) and promotes tumor necrosis factor receptor-associated factor 6-mediated ubiquitination and auto-phosphorylation of TAK1, in which residues 152-161 of TIGAR constitute crucial motif independent of its phosphatase activity. Interference with the binding of TIGAR to TAK1 by 5Z-7-oxozeaenol exhibits therapeutic effects in male murine model of sepsis. These findings demonstrate a non-canonical function of macrophage TIGAR in promoting inflammation, and confer a potential therapeutic target for sepsis by disruption of TIGAR-TAK1 interaction.<br /> (© 2024. The Author(s).)

Details

Language :
English
ISSN :
2041-1723
Volume :
15
Issue :
1
Database :
MEDLINE
Journal :
Nature communications
Publication Type :
Academic Journal
Accession number :
38773142
Full Text :
https://doi.org/10.1038/s41467-024-48708-0